pillbase.ru

Scemblix

Active substance: asciminib

asciminib hydrochloride

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • SCEMBLIX
    TABLET, FILM COATED · ASCIMINIB HYDROCHLORIDE 20 mg/1
    0078-1091
    Novartis Pharmaceuticals Corporation
  • SCEMBLIX
    TABLET, FILM COATED · ASCIMINIB HYDROCHLORIDE 40 mg/1
    0078-1098
    Novartis Pharmaceuticals Corporation
  • SCEMBLIX
    TABLET, FILM COATED · ASCIMINIB HYDROCHLORIDE 100 mg/1
    0078-1196
    Novartis Pharmaceuticals Corporation
  • asciminib
    TABLET, FILM COATED · ASCIMINIB HYDROCHLORIDE 40 mg/1
    17088-0163
    Novartis Pharma Stein AG
  • asciminib
    TABLET, FILM COATED · ASCIMINIB HYDROCHLORIDE 100 mg/1
    17088-0330
    Novartis Pharma Stein AG
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-7d34-77d7-a217-0bedfa759914,01a12091-6cf4-7370-bc65-b7756875332a,01a12091-6cf9-795d-8e9d-4601100a67a1,01a12095-66b9-7ba6-9e41-7189e93079c4,01a12095-7403-7537-b1e0-95d89585289a;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005605
Registration status
Active
ATC code
L01EA06
Sources
  • product · EMA · EMEA/H/C/005605 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005605 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005605 · Verified 2026-10-09